These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8127034)

  • 1. T cells in autoimmunity and allograft rejection.
    Krensky AM
    Kidney Int Suppl; 1994 Jan; 44():S50-6. PubMed ID: 8127034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation by HLA class I-derived peptides.
    Krensky AM; Clayberger C
    Transplant Proc; 1996 Dec; 28(6):3026-8. PubMed ID: 8962174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A.
    Nisco S; Vriens P; Hoyt G; Lyu SC; Farfan F; Pouletty P; Krensky AM; Clayberger C
    J Immunol; 1994 Apr; 152(8):3786-92. PubMed ID: 8144948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigen-derived peptides as novel immunosuppressives.
    Krensky AM; Clayberger C
    Proc Assoc Am Physicians; 1995 Apr; 107(1):81-5. PubMed ID: 8630749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alloimmune response and effector mechanisms of allograft rejection.
    Arakelov A; Lakkis FG
    Semin Nephrol; 2000 Mar; 20(2):95-102. PubMed ID: 10746853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-derived peptides as novel immunosuppressives.
    Krensky AM
    Pediatr Res; 1995 Sep; 38(3):275-9. PubMed ID: 7494646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the TCR binding region of the HLA class I alpha 2 domain in regulation of cell adhesion and proliferation.
    Pettersen RD; Hestdal K; Lie SO; Gaudernack G
    J Immunol; 1996 Feb; 156(4):1415-24. PubMed ID: 8568242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of liver allograft rejection: the indirect recognition pathway.
    Molajoni ER; Cinti P; Orlandini A; Molajoni J; Tugulea S; Ho E; Liu Z; Suciu-Foca N; Cortesini R
    Hum Immunol; 1997 Mar; 53(1):57-63. PubMed ID: 9127148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses.
    Clayberger C; Lyu SC; Pouletty P; Krensky AM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):477-8. PubMed ID: 8438385
    [No Abstract]   [Full Text] [Related]  

  • 13. Engineered promiscuous T helper peptides for the induction of immune responses.
    Ruiz M; Llopiz D; Zabaleta A; Lasarte JJ; Borrás-Cuesta F; Sarobe P
    Mol Immunol; 2007 Mar; 44(9):2205-12. PubMed ID: 17157914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
    Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
    J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
    Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.
    Romagnani C; Pietra G; Falco M; Millo E; Mazzarino P; Biassoni R; Moretta A; Moretta L; Mingari MC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11328-33. PubMed ID: 12167676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis.
    Penzotti JE; Doherty D; Lybrand TP; Nepom GT
    J Autoimmun; 1996 Apr; 9(2):287-93. PubMed ID: 8738976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An HLA-binding-motif-aided peptide epitope library: a novel library design for the screening of HLA-DR4-restricted antigenic peptides recognized by CD4+T cells.
    Tana T; Kamikawaji N; Savoie CJ; Sudo T; Kinoshita Y; Sasazuki T
    J Hum Genet; 1998; 43(1):14-21. PubMed ID: 9609993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.